Title: Study of Microalbuminuria in patients with Hypertension

Authors: Dr Purva Bavikar, Dr Sayali Kusalkar, Dr Jaishree Ghanekar

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i10.126

Abstract

Background: The prevalence of Hypertension is 29.8% in India and is directly responsible for 57% of all stroke deaths and 24% of all coronary heart disease (CHD) deaths

Objective: This study focuses on prevalence of microalbuminuria in hypertension, its correlation with duration and severity of hypertension, and lastly whether microalbuminuria is a useful biomarker for predicting target organ damage.

Material & Methods: The study was conducted in MGM Medical College and Hospital Navi Mumbai for a period of 2 years between 2015 to 2017. Patients between 25 – 60 years of age, with at least 3 readings of increased blood pressures or known hypertension were studied extensively. Univariate analysis (chi square test) was used to determine the relationship between MA and other variables, and the results were expressed as p values.

Results: The overall prevalence of MA in the study was 49% of which 71% were males. 40.82% of patients with microalbuminuria were between 41 – 50 years of age. There was a strong correlation (p < 0.05) between severity of hypertension and MA as 57.74% patients of Stage-2 JNC-7 classification of hypertension had microalbuminuria.

Conclusions: The prevalence of Microalbuminuria, is about 49% among the patients with hypertension. The factors that are positively correlated with microalbuminuria, in the study, are, older age, severity of hypertension.

References

  1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
  2. Raghupathy Anchala, Nanda K. Kannuri, Hira Pant, Hassan Khan, Oscar H. Franco, Emanuele Di Angelantonio, and Dorairaj Prabhakaran Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. Journal of Hypertension 2014 Jun; 32(6): 1170–1177.
  3. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens 2004; 18:73–78
  4. Roland E. Schmieder. End Organ Damage in Hypertension Deutsches Ärzteblatt International. 2010;107(49):866-873.
  5. Inoue T, Iseki K, Higashiuesato Y, Nagahama K, Matsuoka M, Iseki C, et al. Proteinuria as a significant determinant of hypertension in a normotensive screened cohort in Okinawa, Japan. Hypertens Res 2006;29:687-93.
  6. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987;16:235-51.
  7. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D’Agostino RB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005;111:1370-6.
  8. Hitha B, Pappachan J M, Pillai H B, Sujathan P, Ramakrishna C D, Jayaprakash K, Raihanathul Misiriya K J. Microalbuminuria in Patients With Essential Hypertension And its Relationship to Target Organ Damage: An Indian Experience. Saudi J Kidney Dis Transpl 2008;19:411-9.

Corresponding Author

Dr Sayali Kusalkar